Martin Wilson Insider Profile
11 Followers
Martin Wilson, GC at Rocket Pharmaceuticals, holds 598.49K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds 5.00K shares in Teligent (Ticker: TLGTQ). Most recently, Martin Wilson Sold ― shares of Rocket Pharmaceuticals on Sep 15, 2026 for an estimated value of $256.24K.
Profitable Transactions
13 out of 16 Profitable Transactions
Average Return
+28.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
GC
Roles that Martin Wilson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 20, 2024 - Aug 20, 2025
Return:+80.60%
The most profitable trade made by Martin Wilson
Martin Wilson's Trading History
Rocket Pharmaceuticals
Sep 15, 2026
GC
Informative Sell
256.24K
$2.08M
Teligent
―
―
―
$50.00
List of latest transactions for each holding click on a transaction to see Martin Wilson's performance on stock
You May Also Like
Martin Wilson insider profile FAQ
What is the percentage of profitable transactions made by Martin Wilson?
The percentage of profitable transactions made by Martin Wilson is 81%.
What is the average return per transaction made by Martin Wilson?
The average return per transaction made by Martin Wilson is 28.00%.
What stocks does Martin Wilson hold?
Martin Wilson holds: RCKT, TLGTQ stocks.
What was Martin Wilson’s latest transaction?
Martin Wilson latest transaction was an Informative Sell of $256.24K.
What was Martin Wilson's most profitable transaction?
Martin Wilson’s most profitable transaction was an Informative Sell of RCKT stock on August 20, 2024. The return on the trade was 80.60%.
What is Martin Wilson's role in Rocket Pharmaceuticals?
Martin Wilson's role in Rocket Pharmaceuticals is GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.